These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37916489)

  • 1. Drug Discovery Efforts to Identify Novel Treatments for Neglected Tropical Diseases - Cysteine Protease Inhibitors.
    Giroud M; Kuhn B; Haap W
    Curr Med Chem; 2024; 31(16):2170-2194. PubMed ID: 37916489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
    Pereira GAN; da Silva EB; Braga SFP; Leite PG; Martins LC; Vieira RP; Soh WT; Villela FS; Costa FMR; Ray D; de Andrade SF; Brandstetter H; Oliveira RB; Caffrey CR; Machado FS; Ferreira RS
    Eur J Med Chem; 2019 Oct; 179():765-778. PubMed ID: 31284086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
    Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
    Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Top Med Chem; 2021; 21(21):1871-1899. PubMed ID: 33797369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.
    Saha A; Pushpa ; Moitra S; Basak D; Brahma S; Mondal D; Molla SH; Samadder A; Nandi S
    Curr Med Chem; 2024; 31(16):2135-2169. PubMed ID: 37340748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cysteine proteases in trypanosomatid disease drug discovery.
    Ferreira LG; Andricopulo AD
    Pharmacol Ther; 2017 Dec; 180():49-61. PubMed ID: 28579388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Power of Molecular Dynamics Simulations and Their Applications to Discover Cysteine Protease Inhibitors.
    Dos Santos Nascimento IJ; Gomes JNS; de Oliveira Viana J; de Medeiros E Silva YMS; Barbosa EG; de Moura RO
    Mini Rev Med Chem; 2024; 24(11):1125-1146. PubMed ID: 37680157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cysteine-reactive small molecules in drug discovery for trypanosomal disease.
    Nicoll-Griffith DA
    Expert Opin Drug Discov; 2012 Apr; 7(4):353-66. PubMed ID: 22458506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?
    Cianni L; Feldmann CW; Gilberg E; Gütschow M; Juliano L; Leitão A; Bajorath J; Montanari CA
    J Med Chem; 2019 Dec; 62(23):10497-10525. PubMed ID: 31361135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based Approaches Targeting Parasite Cysteine Proteases.
    Vieira RP; Santos VC; Ferreira RS
    Curr Med Chem; 2019; 26(23):4435-4453. PubMed ID: 28799498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria.
    Di Chio C; Starvaggi J; Totaro N; Previti S; Natale B; Cosconati S; Bogacz M; Schirmeister T; Legac J; Rosenthal PJ; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs).
    Previti S; Ettari R; Cosconati S; Amendola G; Chouchene K; Wagner A; Hellmich UA; Ulrich K; Krauth-Siegel RL; Wich PR; Schmid I; Schirmeister T; Gut J; Rosenthal PJ; Grasso S; Zappalà M
    J Med Chem; 2017 Aug; 60(16):6911-6923. PubMed ID: 28763614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
    Mott BT; Ferreira RS; Simeonov A; Jadhav A; Ang KK; Leister W; Shen M; Silveira JT; Doyle PS; Arkin MR; McKerrow JH; Inglese J; Austin CP; Thomas CJ; Shoichet BK; Maloney DJ
    J Med Chem; 2010 Jan; 53(1):52-60. PubMed ID: 19908842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases.
    Silva LR; Guimarães AS; do Nascimento J; do Santos Nascimento IJ; da Silva EB; McKerrow JH; Cardoso SH; da Silva-Júnior EF
    Bioorg Med Chem; 2021 Jul; 41():116213. PubMed ID: 33992862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases.
    Li L; Chenna BC; Yang KS; Cole TR; Goodall ZT; Giardini M; Moghadamchargari Z; Hernandez EA; Gomez J; Calvet CM; Bernatchez JA; Mellott DM; Zhu J; Rademacher A; Thomas D; Blankenship LR; Drelich A; Laganowsky A; Tseng CK; Liu WR; Wand AJ; Cruz-Reyes J; Siqueira-Neto JL; Meek TD
    J Med Chem; 2021 Aug; 64(15):11267-11287. PubMed ID: 34288674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
    Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
    PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine proteases of malaria parasites: targets for chemotherapy.
    Rosenthal PJ; Sijwali PS; Singh A; Shenai BR
    Curr Pharm Des; 2002; 8(18):1659-72. PubMed ID: 12132997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases.
    Eurtivong C; Zimmer C; Schirmeister T; Butkinaree C; Saruengkhanphasit R; Niwetmarin W; Ruchirawat S; Bhambra AS
    Mol Divers; 2024 Apr; 28(2):531-551. PubMed ID: 36617352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8.
    Fey P; Chartomatsidou R; Kiefer W; Mottram JC; Kersten C; Schirmeister T
    Eur J Med Chem; 2018 Aug; 156():587-597. PubMed ID: 30029081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.